Structure of the wild-type human BCL6 POZ domain.
Stead, M.A., Rosbrook, G.O., Hadden, J.M., Trinh, C.H., Carr, S.B., Wright, S.C.(2008) Acta Crystallogr Sect F Struct Biol Cryst Commun 64: 1101-1104
- PubMed: 19052359
- DOI: https://doi.org/10.1107/S1744309108036063
- Primary Citation of Related Structures:
3E4U - PubMed Abstract:
BCL6 is a transcriptional repressor that is overexpressed in diffuse large B-cell lymphoma and follicular lymphoma. The N-terminal POZ domain of BCL6 interacts with transcriptional corepressors and targeting these associations is a promising therapeutic strategy. Previous structural studies of the BCL6 POZ domain have used a mutant form because of the low solubility of the wild-type recombinant protein. A method for the purification and crystallization of the wild-type BCL6 POZ domain is described and the crystal structure to 2.1 A resolution is reported. This will be relevant for the design of therapeutics that target BCL6 POZ-domain interaction interfaces.
Organizational Affiliation:
Molecular Cell Biology Research Group, Garstang/Astbury Buildings, Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, England.